| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 103,754 | 107,851 | 108,847 | 129,529 | | Cost of Revenue | 64,149 | 66,490 | 66,000 | 78,958 | | | Gross Profit | 39,605 | 41,361 | 42,847 | 50,571 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,784 | 33,516 | 33,077 | 37,607 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,821 | 7,845 | 9,770 | 12,964 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 261 | 162 | 103 | (503) | | Earnings Before Interest And Taxes | 8,082 | 8,007 | 9,873 | 12,461 | | Interest Expense | 204 | 122 | 30 | 75 | | Income Before Tax | 7,878 | 7,885 | 9,843 | 12,386 | | Income Tax Expense | 3,210 | 3,214 | 4,010 | 4,976 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,668 | 4,671 | 5,833 | 7,410 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,668 | 4,671 | 5,833 | 7,410 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,668 | $4,671 | $5,833 | $7,410 |
|
0.02% Nasdaq 
2.12 (2.29%) 
Income Statement
